6-APB: Difference between revisions
>Oskykins |
>Oskykins |
||
Line 109: | Line 109: | ||
| [[File:Lolol.png|17px]]''Main articles: [[Research chemicals#Toxicity and harm potential|Research chemicals § Toxicity and harm potential]]'' ''&'' ''[[Responsible use #Hallucinogens|Responsible use § Hallucinogens]]'' | | [[File:Lolol.png|17px]]''Main articles: [[Research chemicals#Toxicity and harm potential|Research chemicals § Toxicity and harm potential]]'' ''&'' ''[[Responsible use #Hallucinogens|Responsible use § Hallucinogens]]'' | ||
|} | |} | ||
Due to only having a short history of human use, the toxicity and harm potential is not exactly known. Due to its simularity to MDMA, it is likely that the administration of repeated or high dosages of 6-APB can be neurotoxic and cardiotoxic<ref> Drug-induced Valvulopathy: An Update | tpx.sagepub.com/content/38/6/837.full</ref><ref>Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/17950805</ref> in some form | Due to only having a short history of human use, the toxicity and harm potential is not exactly known. Due to its simularity to MDMA, it is likely that the administration of repeated or high dosages of 6-APB can be neurotoxic and cardiotoxic<ref> Drug-induced Valvulopathy: An Update | tpx.sagepub.com/content/38/6/837.full</ref><ref>Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/17950805</ref> in some form. | ||
The [[Toxicity::exact toxic dosage is unknown]]. | The [[Toxicity::exact toxic dosage is unknown]]. |